Illumina | ILMN - Ebitda


Illumina reported $330M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Agilent USD 456M 84M Dec/2025
Bio Techne USD 116.71M 13.29M Mar/2026
Bio-Rad Laboratories USD -636.6M 1.62B Mar/2026
Boston Scientific USD 1.63B 27M Jun/2026
Bruker USD 110M 101.6M Mar/2026
Charles River Laboratories USD 229.8M 28.26M Mar/2026
Danaher USD 1.84B 81M Jun/2026
Dentsply International USD 129M 6M Mar/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Illumina USD 330M 80M Jun/2026
Intuitive Surgical USD 1.06B 29.9M Mar/2026
IQVIA Holdings USD 994M 62M Jun/2026
Laboratory Of America USD 767.7M 162.1M Jun/2026
Mettler Toledo International USD 322.64M 43.66M Jun/2026
Myriad Genetics USD 14.3M 4M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Quest Diagnostics USD 648M 91M Jun/2026
Quidel USD 108.7M 44.6M Mar/2026
Repligen USD 43.77M 3.76M Jun/2026
Revvity USD 272.91M 24M Mar/2026
Roche Holding CHF 13.43B 744M Jun/2026
Standard Biotools USD -8.01M 7.8M Mar/2026
Thermo Fisher Scientific USD 3.55B 845M Jun/2026
Waters USD 167M 213.97M Mar/2026